Raj Dinesh, Bhutia Tsultem Doma, Mathur Sandeep, Kabra Sushil Kumar, Lodha Rakesh
Department of Pediatrics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India.
Indian J Pediatr. 2014 Sep;81(9):929-31. doi: 10.1007/s12098-013-1027-6. Epub 2013 May 5.
The authors report an infant with common variable immunodeficiency (CVID) with Pneumocystis pneumonia who developed secondary pulmonary alveolar proteinosis (PAP). This is the youngest infant reported to develop PAP secondary to Pneumocystis infection in an immunocompromised state. He was effectively managed with anti-microbials, frequent lung toilet, optimized mechanical ventilation, and supportive care.
作者报告了一名患有普通可变免疫缺陷（CVID）并伴有卡氏肺孢子虫肺炎的婴儿，该婴儿继发了肺泡蛋白沉积症（PAP）。这是报告中最年幼的在免疫功能低下状态下继发于卡氏肺孢子虫感染而发生PAP的婴儿。他通过使用抗菌药物、频繁肺部灌洗、优化机械通气和支持性护理得到了有效治疗。
